Global Certificate in Drug Discovery: Future-Ready Strategies
-- ViewingNowThe Global Certificate in Drug Discovery: Future-Ready Strategies is a comprehensive course designed to empower learners with essential skills for success in the evolving pharmaceutical industry. This certificate program highlights the latest trends, technologies, and strategies in drug discovery, fostering a deep understanding of the entire process from target identification to clinical trials.
6,309+
Students enrolled
GBP £ 149
GBP £ 215
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Drug Discovery Fundamentals: An introduction to drug discovery, including historical context, current trends, and future directions. This unit will cover the basic principles of drug discovery, from target identification to preclinical and clinical development.
⢠Target Identification and Validation: This unit will focus on the initial stages of drug discovery, including target identification, validation, and selection. It will cover various approaches for target identification, such as genomics, proteomics, and bioinformatics, as well as methods for validating targets, such as in vitro and in vivo assays.
⢠Hit Finding and Lead Optimization: This unit will cover the process of identifying hit compounds and optimizing them for further development. It will discuss various high-throughput screening techniques, including biochemical, biophysical, and cell-based assays, as well as medicinal chemistry approaches for lead optimization.
⢠Drug Metabolism and Pharmacokinetics (DMPK): This unit will focus on the absorption, distribution, metabolism, and excretion (ADME) of drugs, including the impact of DMPK on drug safety and efficacy. It will cover various in vitro and in vivo models for predicting drug disposition and pharmacokinetics, as well as strategies for optimizing drug properties.
⢠Preclinical Development and Safety Assessment: This unit will cover the preclinical development of drugs, including safety assessment, toxicity testing, and regulatory requirements. It will discuss various in vitro and in vivo models for predicting drug safety, as well as strategies for mitigating risks and ensuring regulatory compliance.
⢠Clinical Development and Translation: This unit will focus on the clinical development of drugs, including study design, clinical trial execution, and regulatory approval. It will cover various clinical trial phases, including Phase 1, 2, and 3 trials, as well as strategies for translating preclinical findings into clinical applications.
⢠Artificial Intelligence (AI) and Machine Learning (ML
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëʏ
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë